Cocrystal Pharma COCP
NASDAQ COCP
$0.96 +0.02 (+1.81%)
As of: Oct 21, 2026 · 3:20 PM EDT

Cocrystal Pharma (COCP) Construction in Progress (2015 - 2016)

Updated

Cocrystal Pharma's Construction in Progress was $146.3 million in Q3 2016.

Analysis

Cocrystal Pharma (COCP) Construction in Progress (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Cocrystal Pharma 13.24 Mn -8.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 146.30 Mn
Dec 31, 2015 146.30 Mn
API Access

Cocrystal Pharma Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=COCP&period=max&api_key=YOUR_API_KEY